MHRA approves over-the-counter allergy treatment

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the reclassification of fluticasone propionate (Pirinase Allergy 0.05% w/w Nasal Spray), making it available directly from behind pharmacy counters, without the need for a prescription, for adolescents aged 12 years and over.

Read the full press release here.

Dr Gary Stiefel, chair of the Allergy UK Health Advisory Board and a consultant in paediatric allergy, said:

Fluticasone proportionate 0.05% nasal spray is extremely safe and can be very effective if used alone or in conjunction with non-sedating antihistamines for the treatment of hay fever.

Its use in children from 12 years of age will significantly help large numbers of children who suffer from hay fever and we are supportive of this additional medicine.

It is important to ensure that young people are shown how to use the device correctly.

Often individuals fail to correctly use their nasal spray experience reduced effectiveness in soothing their hay fever symptoms. Whether due to incorrect dosage, improper technique, or inconsistent use, not adhering to the recommended application can result in a lessened impact on symptom relief. Find out how to effectively administer your nasal spray.